
Michael R. Hayden
Director · AbCellera Biologics Inc.
- 2024
- Aug 24, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael R. Hayden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brett P. Monia - $30.32M in IONS purchases and sales in the last 12 months
- Elizabeth L. Hougen - $17.87M in IONS purchases and sales in the last 12 months
- C. Frank Bennett - $16.71M in IONS purchases and sales in the last 12 months
- Richard S. Geary - $9.45M in IONS purchases and sales in the last 12 months
- Joseph Loscalzo - $7.09M in IONS purchases and sales in the last 12 months
- Joseph Klein III - $6.00M in IONS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael R. Hayden?
Michael R. Hayden is a corporate insider, tracked as Director of AbCellera Biologics Inc. (ABCL). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael R. Hayden submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Michael R. Hayden been buying or selling stock?
Recorded transactions: 6 open-market purchases ($2.29M) and 0 open-market sales across all tracked filings.